Industry Newsroom

Share Capital Leads USD93m Series C for China’s Binhui Biotech

Share Capital led a CNY600m (approximately USD93m) Series C for Binhui Biotech, a China-based biotechnology company focused on the development of oncology immunotherapies, with participation from CICC Capital, Vertex Ventures China, and Shenzhen Capital Group, and follow-on from Lapam Capital. Read more